Lone Star Value Investors’s Enzo Biochem, Inc. ENZ Stock Holding History

Lone Star Value Investors’s Portfolio ENZ Stock Details ENZ Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2015 Q1	$593K	Buy	+201,000	New	+$658K	0.69%	14

Other funds holding ENZ

Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return

Dimensional Fund Advisors Austin, Texas $481B AUM 30.42% 1-Year Est. Return

BIT

BlackRock Institutional Trust San Francisco, California $675B AUM 16.26% 1-Year Est. Return

FLAM

First Light Asset Management Edina, Minnesota $1.12B AUM 114.45% 1-Year Est. Return

Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

TAM

THB Asset Management Norwalk, Connecticut $440M AUM 59.59% 1-Year Est. Return

BFA

BlackRock Fund Advisors San Francisco, California $542B AUM 18.14% 1-Year Est. Return

Allianz Asset Management Munich, Germany $95.4B AUM 38.74% 1-Year Est. Return

Millennium Management New York $240B AUM 35.51% 1-Year Est. Return

Lone Star Value Investors's ENZ Position: Q1 2015 in Review

Lone Star Value Investors opened a new position in Enzo Biochem, Inc. (ENZ) in Q1 2015: 201,000 shares worth $593K. The stake represents 0.69% of the portfolio and ranks #14 among its holdings.

90 funds tracked by Wall St. Rank hold ENZ as of Q1 2015.

Lone Star Value Investors held 201,000 shares of Enzo Biochem, Inc. worth $593K as of Q1 2015.
Enzo Biochem, Inc. was a new Lone Star Value Investors position in Q1 2015.
Enzo Biochem, Inc. made up 0.69% of Lone Star Value Investors's portfolio in Q1 2015, its #14 holding.
90 funds tracked by Wall St. Rank held Enzo Biochem, Inc. as of Q1 2015.

Based on Lone Star Value Investors's 13F filing for Q1 2015, filed 15 May 2015.